Foss Family Trusts Extend Selling Streak with $9.3M Proposed Sale by Eidolon Corvid 2024 Trust
CACC sits 56% above its 52-week low of $401.9.
Summary
A trust linked to the Foss family, a 10% holder, plans to sell $9.3 million in Credit Acceptance Corp stock, extending a notable insider-selling trend.
Key Events · Ownership and Investor Activity · CACC
-
New Form 144 from Foss Family Trust
On 07/09/2026, the Eidolon Corvid 2024 Trust—an immediate family member of a 10% holder—filed to sell 15,000 shares, valued at approximately $9.3 million.
-
Aggregate Selling Across Trusts
Remarks show that proposed sales across multiple trusts could reach up to 93,934 shares, with Todd Watson acting as trustee and spouse of 10% holder Jill Foss Watson.
-
Ongoing Insider Distribution
This filing adds to a significant insider-selling pattern: over the past 90 days, 8 insiders have recorded net sales of $70.5 million, including prior Form 144s by related trusts.
Analysis · CACC · Finance
A fresh Form 144 reveals that the Eidolon Corvid 2024 Trust—an immediate family member of a 10% holder—intends to sell 15,000 shares, worth roughly $9.3 million. The move deepens an already heavy insider-selling pattern among Foss family trusts, where aggregate proposed sales across multiple entities now total 93,934 shares. Although the trust is not a company officer, the sustained distribution by vehicles tied to the founding family raises conviction concerns, particularly against a backdrop of $70 million in net insider sales over the past 90 days.
How filings like this one have moved
In the 30 days to Aug 23, 2026, 29.5% of the 2875 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CACC was trading at $627.11 on NASDAQ in the Finance sector, with a market capitalization of approximately $6.6B. The 52-week trading range was $401.90 to $668.86. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.